INTERNATIONAL PATENT: M6P THERAPEUTICS (SWITZERLAND) GMBH FILES APPLICATION FOR "LYSOSOME-TARGETING DEGRADATION FUSION DESIGN"

GENEVA, Nov. 24 -- M6P THERAPEUTICS (SWITZERLAND) GMBH (c/o Bovadis Partner Treuhand AGHerrenacker 158200 Schaffhausen) filed a patent application (PCT/EP2025/063284) for "LYSOSOME-TARGETING DEGRADATION FUSION DESIGN" on May 14, 2025. With publication no. WO/2025/238106, the details related to the patent application was published on Nov 20, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): LIU, Lin (11 Windsor LaneBallwin, Missouri 63011)

Abstract: Provided herein is disclosure of a recombinant bifunctional protein or polypeptide capable of binding to a cell surface receptor for lysosome targ...